TY - JOUR AU - Iwamoto, T. AU - Bianchini, G. AU - Booser, D. PY - 2011 DA - 2011// TI - Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer JO - J Natl Cancer Inst VL - 103 UR - https://doi.org/10.1093/jnci/djq524 DO - 10.1093/jnci/djq524 ID - Iwamoto2011 ER - TY - JOUR AU - Bianchini, G. AU - Iwamoto, T. AU - Coutant, C. PY - 2010 DA - 2010// TI - Prognostic and therapeutic implications of distinct kinase expression patterns in different subtypes of breast cancer JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-1039 DO - 10.1158/0008-5472.CAN-10-1039 ID - Bianchini2010 ER - TY - JOUR AU - Coutant, C. AU - Rouzier, R. AU - Qi, Y. PY - 2011 DA - 2011// TI - Distinct p53 gene signatures are needed to predict prognosis and response to chemotherapy in ER-positive and ER-negative breast cancers JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-1045 DO - 10.1158/1078-0432.CCR-10-1045 ID - Coutant2011 ER - TY - JOUR AU - Tordai, A. AU - Wang, J. AU - Andre, F. PY - 2008 DA - 2008// TI - Evaluation of biological pathways involved in chemotherapy response in breast cancer JO - Breast Cancer Res VL - 10 UR - https://doi.org/10.1186/bcr2088 DO - 10.1186/bcr2088 ID - Tordai2008 ER - TY - CHAP AU - Karn, T. AU - Pusztai, L. AU - Ruckhaeberle, E. PY - 2011 DA - 2011// TI - Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation BT - Eur J Cancer ID - Karn2011 ER - TY - JOUR AU - Bianchini, G. AU - Qi, Y. AU - Hugo, A. R. PY - 2010 DA - 2010// TI - Molecular anatomy of breast cancer stroma and its prognostic value in ER-positive and-negative cancers JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.27.2419 DO - 10.1200/JCO.2009.27.2419 ID - Bianchini2010 ER - TY - JOUR AU - Andre, F. AU - Hatzis, C. AU - Anderson, K. PY - 2007 DA - 2007// TI - Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2078 DO - 10.1158/1078-0432.CCR-06-2078 ID - Andre2007 ER - TY - JOUR AU - Pusztai, L. AU - Broglio, K. AU - Andre, F. PY - 2008 DA - 2008// TI - Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen-receptor positive breast cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.17.2544 DO - 10.1200/JCO.2008.17.2544 ID - Pusztai2008 ER - TY - JOUR AU - Sotiriou, C. AU - Pusztai, L. PY - 2009 DA - 2009// TI - Gene expression signatures in breast cancer JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMra0801289 DO - 10.1056/NEJMra0801289 ID - Sotiriou2009 ER -